UPLOAD Filing
Benitec Biopharma Inc.
Date: May 29, 2025 · CIK: 0001808898 · Accession: 0000000000-25-005638
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287566
Letter
Re: Benitec Biopharma Inc. Registration Statement on Form S-3 Filed May 23, 2025 File No. 333-287566 Dear Jerel Banks:
May 28, 2025
Jerel Banks Chief Executive Officer Benitec Biopharma Inc. 3940 Trust Way Hayward, CA 94545
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Matt O Loughlin
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 28, 2025 Jerel Banks Chief Executive Officer Benitec Biopharma Inc. 3940 Trust Way Hayward, CA 94545 Re: Benitec Biopharma Inc. Registration Statement on Form S-3 Filed May 23, 2025 File No. 333-287566 Dear Jerel Banks: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matt O Loughlin </TEXT> </DOCUMENT>